Ketoconazole, Serum or Plasma
Also known as: Nizoral®
Use
Treatment of susceptible fungal infections, including candidiasis, oral thrush, blastomycosis, histoplasmosis, paracoccidiodomycosis, coccidioidomycosis, chromomycosis, chronic muccotaneous candidiasis, as well as recalcitrant cutaneous dematophytoses.
Special Instructions
Ensure that serum or plasma is transferred to a plastic transport tube and not a gel barrier tube due to potential drug absorption by the gel, which can affect the drug level significantly.
Limitations
This test was developed by LabCorp, and its performance characteristics have been determined internally. It has not been cleared or approved by the United States Food and Drug Administration (FDA), although FDA clearance or approval is not deemed necessary. The use of gel-barrier tubes is restricted because they can cause a clinically significant decrease in drug levels due to absorption.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 10990-0
- 10990-0
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or lavender-top (EDTA) tube
Collection Instructions
Transfer separated serum or plasma to a plastic transport tube. Avoid using gel barrier tubes.
Storage Instructions
Refrigerate. Stable for 14 days at room temperature, refrigerated, or frozen.
Causes for Rejection
Gel-barrier tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |